Showing 1 - 10 of 436
We study effects of direct-to-consumer advertising (DTCA) in a market with two pharmaceutical firms providing horizontally differentiated (branded) drugs. Patients varying in their susceptability to medication are a priori uninformed of available medication. Physicians making the prescription...
Persistent link: https://www.econbiz.de/10008914353
We study effects of direct-to-consumer advertising (DTCA) in the prescription drug market. There are two pharmaceutical firms providing horizontally differentiated (branded) drugs. Patients differ in their susceptibility to the drugs. If DTCA is allowed, this can be employed to induce...
Persistent link: https://www.econbiz.de/10005406241
Persistent link: https://www.econbiz.de/10005204361
Persistent link: https://www.econbiz.de/10001753090
Persistent link: https://www.econbiz.de/10001774715
We study effects of direct-to-consumer advertising (DTCA) in the prescription drug market. There are two pharmaceutical firms providing horizontally differentiated (branded) drugs. Patients differ in their susceptibility to the drugs. If DTCA is allowed, this can be employed to induce...
Persistent link: https://www.econbiz.de/10003110551
We study effects of direct-to-consumer advertising (DTCA) in the prescription drug market. There are two pharmaceutical firms providing horizontally differentiated (branded) drugs. Patients differ in their susceptibility to the drugs. If DTCA is allowed, this can be employed to induce...
Persistent link: https://www.econbiz.de/10003041694
Persistent link: https://www.econbiz.de/10003251296
Persistent link: https://www.econbiz.de/10003892948
Persistent link: https://www.econbiz.de/10002053867